Topical Minoxidil vs Spironolactone: Side-Effect Profile Head-to-Head
A direct comparison of topical minoxidil 5% and oral spironolactone side effects, efficacy data, and clinical use cases for hair loss and hormonal acne in women.
Tretinoin vs Avodart: Cost and Access Head-to-Head
A detailed clinical comparison of tretinoin (topical retinoid) and Avodart (dutasteride) covering indications, efficacy data, cost, insurance coverage, and telehealth access for patients and clinicians.
Tretinoin vs Avodart: What They Treat, How They Differ, and When to Switch
A clinical comparison of tretinoin (topical retinoid) and Avodart (dutasteride) covering mechanisms, evidence, and the decision framework for switching between them.
Tretinoin vs Accutane (Isotretinoin): Cost and Access Head-to-Head
A detailed clinical comparison of tretinoin topical and oral isotretinoin covering efficacy, cost, access requirements, side-effect profiles, and how to choose between them for acne and skin concerns.
Tretinoin vs Topical Minoxidil: Switching Between Them
A comparison of tretinoin and topical minoxidil, covering mechanisms, clinical evidence, and how to switch safely between them for skin and hair goals.
Lunesta vs Trazodone: Combining the Two (Rationale + Risk)
A clinical comparison of eszopiclone (Lunesta) and trazodone for insomnia, including the evidence base for combining them, pharmacology, switching protocols, and safety data prepared by the HealthRX.com Editorial Team.
Lunesta vs Trazodone: Switching Between Them Safely
A comparison of eszopiclone (Lunesta) and trazodone for insomnia, including how to switch between them, dosing, safety data, and which patients do better on each drug.
Belsomra vs Dayvigo: Switching Between Suvorexant and Lemborexant
A clinical comparison of suvorexant (Belsomra) and lemborexant (Dayvigo) covering efficacy, safety, next-morning alertness, and a step-by-step protocol for switching between them.
Liraglutide vs Retatrutide: Products, Combination and Access
Liraglutide and retatrutide: what studies show, whether switching or combining is established, and how product, access and population differences matter.
Oral Estradiol vs Vaginal Estradiol: Side-Effect Profile Head-to-Head
A detailed clinical comparison of oral estradiol and vaginal estradiol side-effect profiles, covering systemic absorption, VTE risk, breast tissue exposure, and when each route is the right choice for menopausal women.
Estradiol Patch vs Oral Estradiol: Cost and Access Head-to-Head
A clinical comparison of estradiol patch versus oral estradiol covering pharmacokinetics, safety, cost, insurance coverage, and access, with primary-source citations throughout.
Estradiol Patch vs Oral Estradiol: Head-to-Head Efficacy Compared
A clinical comparison of transdermal estradiol patch vs oral estradiol for menopausal HRT. Covers efficacy, VMS relief, cardiovascular risk, clot risk, bone protection, and how to choose.
Oral Micronized Progesterone vs Oral Estradiol: Head-to-Head Efficacy
A clinical comparison of oral micronized progesterone (Prometrium) and oral estradiol for menopausal HRT, covering endometrial protection, vasomotor symptom relief, cardiovascular effects, bone density, and safety profiles with trial data.
Oral Micronized Progesterone vs Prometrium: Head-to-Head Efficacy
A detailed clinical comparison of oral micronized progesterone and Prometrium for women's HRT, including trial data, dosing, safety profiles, and when each is preferred.
Male Hypogonadism: How to Stop Treatment Safely
A guide to stopping testosterone replacement therapy for male hypogonadism safely, including tapering protocols, HPG axis recovery, and monitoring schedules backed by Endocrine Society guidelines.
Menopause and Mental Health: What the Overlap Really Means for Your Treatment
Perimenopause and menopause drive real psychiatric symptoms including depression, anxiety, and cognitive changes. Learn how to diagnose the overlap, which treatments work, and what major society guidelines recommend.
Menopause Relapse Prevention Strategies: A Complete Clinical Guide
Evidence-based strategies to prevent the return of menopause symptoms, protect bone density, support cardiovascular health, and sustain quality of life. prepared by the HealthRX.com Editorial Team.
Metabolic Syndrome Diagnostic Algorithm: Step by Step
A clinician-grade, step-by-step guide to diagnosing metabolic syndrome using ATP III, IDF, and harmonized AHA/NHLBI criteria, plus evidence-based treatment pathways for all five components.
Obesity (BMI ≥30) Partner and Family Role: A Complete Clinical Guide
How partners and family members can support obesity treatment. Evidence-based strategies covering shared lifestyle change, emotional support, medication adherence, and what the guidelines say.
Obesity (BMI ≥30) Racial and Ethnic Disparities
A clinical deep-dive into why Black, Hispanic, Native American, and Pacific Islander adults carry a disproportionate burden of obesity, what drives those gaps, and how current guidelines address them.
Obstructive Sleep Apnea (OSA) Diagnostic Algorithm, Step by Step
A complete walkthrough of the OSA diagnostic algorithm: screening tools, home vs. Lab sleep testing, AHI thresholds, severity classification, and first-line treatment options including CPAP, weight loss, and tirzepatide (Zepbound).
PCOS (Polycystic Ovary Syndrome) Caregiver and Family Resources
A guide for caregivers and family members supporting someone with PCOS. Covers diagnosis, treatment options, emotional support strategies, and when to seek specialist care.
PCOS and Mental Health: Understanding the Overlap Between Polycystic Ovary Syndrome and Anxiety, Depression, and Beyond
PCOS is a hormonal and metabolic condition that affects an estimated 6-12% of reproductive-age women and is associated with a meaningfully higher rate of depression, anxiety, and disordered eating. This article explains the plausible mechanisms, how clinicians screen, what treatments have evidence behind them, and where the research is still incomplete.
PCOS Treatment Algorithm: First, Second, and Third-Line Therapy Explained
An evidence-based PCOS treatment algorithm organized by line of therapy, covering lifestyle, metformin, combined oral contraceptives, letrozole, GLP-1 agonists, and surgical options with full citations.
Perimenopause Common Comorbidities and Overlap: What Clinicians and Patients Need to Know
A clinical guide to the conditions that commonly co-occur with perimenopause, including thyroid disease, metabolic syndrome, mood disorders, sleep disturbance, and cardiovascular risk, with guidance on what to screen for and when to escalate care.
Perimenopause Financial Planning by Stage: What Every Woman Should Budget For
A stage-by-stage guide to the real costs of perimenopause care, from early irregular cycles through late-stage vasomotor symptoms, including medication costs, lab work, and when to seek specialist care.
Perimenopause Genetics and Family History: What Your DNA and Family Tree Mean for Your Transition
Learn how genetics and family history shape perimenopause timing, symptom severity, and treatment options. Evidence-based guidance from the HealthRX.com medical team, with citations to primary research.
Cuál es el porcentaje de mujeres en perimenopausia global
1.1 mil millones de mujeres estarán en o tras la transición menopáusica para 2025, con 47 millones entrando en perimenopausia cada año.
Perimenopause Partner and Family Role: A Complete Guide
How partners and family members can support someone through perimenopause, including symptom education, communication strategies, and when to encourage professional care.
Perimenopause Treatment Algorithm by Line of Therapy
A guideline-based treatment algorithm for perimenopause: first-line, second-line, and third-line options for vasomotor symptoms, cycle irregularity, mood disturbance, and bone protection, with dosing, evidence grades, and society recommendations.
Prediabetes and Mental Health: The Bidirectional Link Explained
Prediabetes and mental health disorders share overlapping biology, risk factors, and treatment gaps. Learn how depression, anxiety, and chronic stress drive glucose dysregulation, and what clinical guidelines say about screening and treating both.
Secondary Hypogonadism: Common Comorbidities and Clinical Overlap
A guide to secondary hypogonadism comorbidities, including type 2 diabetes, obesity, sleep apnea, hyperprolactinemia, and opioid use, with diagnostic criteria, treatment options, and Endocrine Society guideline references.
Secondary Hypogonadism Exercise Prescription: What the Evidence Actually Supports
A guide to exercise protocols for secondary hypogonadism, covering resistance training, HIIT, aerobic work, and how structured movement affects LH, FSH, and testosterone recovery.
Tendinopathy Treatment Algorithm by Line of Therapy
An evidence-based treatment algorithm for tendinopathy covering first-line load management and eccentric exercise through third-line PRP, BPC-157, and surgical referral, with citations to primary RCTs and society guidelines.
Established Cardiovascular Disease: Emerging Mechanism Research
A review of mechanistic research beyond LDL-lowering in established cardiovascular disease, covering inflammation, clonal hematopoiesis, gut microbiome signaling, Lp(a), and GLP-1 receptor agonists, with notes on evidence strength and what remains unproven.
Metabolic Syndrome Global Prevalence and Trends
How common is metabolic syndrome worldwide? Epidemiology data, regional breakdowns, rising trends, diagnostic criteria, and clinical guidance from primary sources.
Metabolic Syndrome Socioeconomic Impact: Costs, Disparities, and What Drives Them
Metabolic syndrome affects 1 in 3 U.S. Adults and generates hundreds of billions in annual healthcare costs. This guide covers the economic burden, racial and income disparities, productivity losses, and evidence-based interventions that reduce both health and financial harm.
NAFLD / MASLD History of Treatment Over Decades
A clinical history of NAFLD and MASLD treatment from the 1980s to today, covering lifestyle interventions, vitamin E, pioglitazone, and the first FDA-approved therapy resmetirom, with primary-source citations throughout.
NAFLD / MASLD Racial and Ethnic Disparities: Prevalence, Mechanisms, and Clinical Guidance
A comprehensive clinical review of racial and ethnic disparities in NAFLD / MASLD prevalence, severity, genetics, and treatment access, with primary-source citations and guidance.
Obstructive Sleep Apnea (OSA) Emerging Mechanism Research
A deep dive into the latest OSA mechanism research: loop gain, arousal threshold, upper-airway muscle dysfunction, hypoxic signaling, and GLP-1 pathway discoveries that are reshaping treatment strategy.
Obstructive Sleep Apnea (OSA): History of Treatment Over Decades
A comprehensive clinical history of obstructive sleep apnea treatment from tracheotomy in the 1960s through CPAP, oral appliances, surgery, and the emerging GLP-1 era, with primary-source citations throughout.
Obstructive Sleep Apnea Racial and Ethnic Disparities: What the Evidence Shows
Black, Hispanic, Asian, and Native American populations face higher OSA prevalence, later diagnosis, and worse outcomes than white patients. Learn what drives these gaps and what clinicians can do.
Post-Surgical Recovery: Open Controversies in the Field
A look at the most contested questions in post-surgical recovery, from opioid-sparing protocols to optimal nutrition timing, with primary-source citations and practical guidance.
Post-Surgical Recovery Racial and Ethnic Disparities: What the Evidence Shows
A clinical review of racial and ethnic disparities in post-surgical recovery, covering pain management, complication rates, readmission, and evidence-based strategies to close the gap.
Post-Surgical Recovery Socioeconomic Impact: Costs, Lost Wages, and the Burden on Patients and Families
A deep dive into the socioeconomic impact of post-surgical recovery, covering direct medical costs, lost productivity, caregiver burden, and disparities in recovery outcomes across income and insurance strata.
Prediabetes Open Controversies in the Field
A clinically rigorous review of the most contested debates in prediabetes research: diagnostic thresholds, reversal definitions, treatment with metformin, overdiagnosis risk, and what current guidelines actually recommend.
Prediabetes History of Treatment Over Decades
A clinical deep-dive into how prediabetes treatment has evolved from lifestyle-only advice in the 1980s through modern pharmacotherapy and precision medicine, with primary-source citations and actionable guidance.
Prediabetes Racial and Ethnic Disparities: Prevalence, Risk, and What to Do About It
Why prediabetes rates differ sharply by race and ethnicity, which populations carry the highest burden, and what ADA and USPSTF guidelines recommend for equitable screening and treatment.
Tendinopathy: Open Controversies in the Field
A review of the most contested clinical questions in tendinopathy management, from diagnosis and pathology staging to loading protocols, injections, biologics, and surgery thresholds, with an honest account of where the evidence is solid and where it is not.
Tendinopathy Emerging Mechanism Research: What the Latest Science Reveals
An evidence-based review of the emerging biological mechanisms driving tendinopathy, including neurogenic inflammation, failed healing responses, metabolic drivers, and new therapeutic targets backed by primary-source research.
Tendinopathy Socioeconomic Impact: Costs, Disability, and the Burden on Patients and Health Systems
A clinical overview of the socioeconomic burden of tendinopathy, covering direct medical costs, productivity losses, disability rates, and evidence-based management strategies that reduce long-term expenses.
Type 2 Diabetes Racial and Ethnic Disparities: Prevalence, Causes, and Clinical Action
A comprehensive, evidence-based review of how race and ethnicity shape type 2 diabetes risk, diagnosis, complications, and treatment access, with primary-source citations throughout.
Type 2 Diabetes Socioeconomic Impact: Costs, Disparities, and What the Data Actually Show
A clinically grounded review of the socioeconomic burden of type 2 diabetes, direct medical costs, lost productivity, racial and income disparities, and actionable strategies backed by primary trial and guideline data.
Farxiga Appetite & Cravings Changes: What the Clinical Evidence Shows
Does Farxiga (dapagliflozin) reduce appetite or change food cravings? A PharmD/MD-level review of the mechanisms, clinical trial data, and what patients can realistically expect.
Farxiga Mental Health and Mood Impact: What the Evidence Actually Shows
A clinical deep-dive into how dapagliflozin (Farxiga) affects mental health, mood, depression risk, and quality of life. Covers DAPA-HF, DAPA-CKD, and emerging mechanistic data with physician-level citations.
Farxiga Sleep Architecture Impact: What Dapagliflozin Does to Your Sleep
A clinician-level review of how dapagliflozin (Farxiga) affects sleep architecture, nocturia, OSA-related outcomes, and cardiorespiratory physiology, with primary-literature citations.
Prolia (Denosumab) Cognitive Function Impact: What the Evidence Actually Shows
A deep-dive into denosumab (Prolia) and cognition: RANKL biology, FREEDOM trial data, pharmacovigilance signals, and clinical decision-making for patients concerned about brain fog or cognitive decline.
Prolia (Denosumab) Pre-Surgery Hold Window: What Clinicians Need to Know
A comprehensive clinical guide to the denosumab pre-surgery hold window, covering fracture rebound risk, optimal timing, bridging strategies, and evidence-based protocols for perioperative management of Prolia patients.
Inositol for PCOS: Supplement-Based Approach, 2011-2015 Trials
Randomized trials from 2011-2015 show myo-inositol restores ovulation in up to 62% of PCOS patients versus 27% on placebo, rivaling metformin.
How Does Inflammation Actually Affect Weight Gain and Metabolic Health?
A deep dive into the bidirectional relationship between chronic low-grade inflammation, weight gain, insulin resistance, and metabolic disease, with specific clinical data, named trials, and actionable guidance.